Lassa fever – Full recovery without Ribavarin treatment: A case report

African Health Sciences

Volumn 14, Issue 4, 2014, Pages 1074-1077

  Ajayi, Nnennaya A ^a   Ukwaja, Kingsley N ^a   Ifebunandu, Ngozi A ^a   Nnabu, Richard ^a   Onwe, Francis I ^a,b   Asogun, Danny A ^c  

^a Federal Teaching Hospital Abakaliki   (Nigeria)

^b Imo State Ministry of Health   (Nigeria)

^c IRRUA SPECIALIST TEACHING HOSPITAL   (Nigeria)

Author keywords

Lassa fever; Ribavarin; Survival; Viral hemorrhagic fever

Indexed keywords

ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ASPARTATE AMINOTRANSFERASE; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; QUININE; RIBAVIRIN; VITAMIN B COMPLEX; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIURIA; CASE REPORT; CHILL; CRACKLE; DISEASE SEVERITY; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HEADACHE; HEMATEMESIS; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LASSA FEVER; LEUKOCYTE COUNT; LEUKOPENIA; LYMPHOCYTOSIS; MIDDLE AGED; NEUTROPENIA; PARESTHESIA; PLASMODIUM MALARIAE INFECTION; PROTEINURIA; PYELONEPHRITIS; RETICULOCYTE COUNT; SEPSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; WEAKNESS; FATALITY; GENETICS; ISOLATION AND PURIFICATION; LASSA VIRUS; MORTALITY; POLYMERASE CHAIN REACTION;

ANTIVIRAL AGENTS; FATAL OUTCOME; FEMALE; FEVER; HUMANS; LASSA FEVER; LASSA VIRUS; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 84921631728     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v14i4.40     Document Type: Article

References (14)

1. Frame JD, Baldwin JM, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 1970; 19 (4): 670–6.
2. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, et al. A case- control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 1987; 155 (3): 445-55.
3. Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West Africa sub region: an overview. J Vect Borne Dis 2007; 44 (1): 1–11
4. Ajayi NA, Nwigwe CG, Azuogu BN, Onyire BN, Nwonwu EU, Ogbonnaya LU, et al. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012). Int J Infect Dis 2013; 17: e1011-e1016
5. Leifer E, Gocke DJ, Bourne H. Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg 1970; 19 (4): 677-9
6. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever: effective therapy with ribavarin. N Engl J Med 1986; 314 (1): 20–26
7. Centers for Disease Control and Prevention and World Health Organization. Technical guidelines for integrated disease surveillance and response in the African region. Atlanta: Center for Disease Control and Prevention, 2010:1–416
8. Asogun DA, Adomeh DI, Ehimuan J, Odia I, Hass M, Gabriel M, et al. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis 2012; 6 (9): e1839
9. Troup JM, White HA, Fom AL, Carey DE. An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report. Am J Trop Med Hyg 1970; 19 (4): 695-6.
10. Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavarin as post-exposure prophylaxis for Lassa fever. Clin Infect Dis 2010; 51 (12): 1435-41
11. Olschläger S, Lelke M, Emmerich P, Panning M, Drosten C, Hass M, et al., Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol 2010; 48 (6): 2009-13.
12. Haas WH, Breuer T, Pfaff G, Schmitz H, Köhler P, Asper M et al., Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 2003; 36 (10): 1254-1258
13. Helmick CG, Webb PA, Scribner CL, Krebs JW, Mc-Cormick JB. No evidence for increased risk of Lassa fever infection in hospital staff. Lancet 1986; 2 (8517): 1202–1205
14. Mbonye A, Wamala J, Winyi Kaboyo, Tugumizemo V, Aceng J, Makumbi I. Repeated outbreaks of viral hemorrhagic fevers in Uganda. Afr Health Sci 2012; 12 (4): 579-83.